Candel Therapeutics, Inc.CADLEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Candel Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing oncolytic immunotherapies for cancer treatment. Its product pipeline covers solid tumors and hematological malignancies, serving global oncology markets and addressing unmet medical needs for patients with limited treatment options.